Cyclooxygenase-2-Induces EP1- and HER-2/Neu-Dependent Vascular, Endothelial Growth Factor-C Up-Regulation: A Novel Mechanism of Lymphangiogenesis in Lung Adenocarcinoma

Cancer Research

Volumn 64, Issue 2, 2004, Pages 554-564

  Su, Jen Liang ^a   Shih, Jin Yuan ^b   Yen, Men Luh ^b   Jeng, Yung Ming ^b   Chang, Cheng Chi ^a   Hsieh, Chang Yao ^b   Wei, Lin Hung ^b   Yang, Pan Chyr ^b   Kuo, Min Liang ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROSTAGLANDIN E2; PROTEIN TYROSINE KINASE; VASCULOTROPIN C; VASCULOTROPIN D;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TRANSACTIVATION; TUMOR CELL LINE; TUMOR GROWTH; WESTERN BLOTTING;

ADENOCARCINOMA; CELL LINE, TUMOR; CLONING, MOLECULAR; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION; HUMANS; ISOENZYMES; KINETICS; LUNG NEOPLASMS; LYMPHANGIOGENESIS; MEMBRANE PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTOR, ERBB-2; RECEPTORS, PROSTAGLANDIN E; THIONUCLEOTIDES; TIME FACTORS; TRANS-ACTIVATION (GENETICS); VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 1642475162     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-1301     Document Type: Article

References (57)

1. Jain, R. K., and Fenton B. T. Intratumoral lymphatic vessels: a case of mistaken identity or malfunction? J. Natl. Cancer Inst. (Bethesda), 94: 417-421, 2002.
2. Wu, K. K. Inducible cyclooxygenase and nitric oxide synthase. Adv. Pharmacol., 33: 179-207, 1995.
3. Vane, J. R., Mitchell, J. A., Appleton, I., Tomlinson, A., Bishop-Bailey, D., Croxtall, J., and Willoughby, D. A. Inducible isoforms of cyclooxygenase and nitric oxide synthase in inflammation. Proc. Natl. Acad. Sci. USA., 91: 2046-2050, 1994.
4. Tsujii, M., Kawano, S., and DuBois, R. N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. USA, 94: 3336-3340, 1997.
5. Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., and Hla, T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55: 3785-3789, 1995.
6. Ristimaki, A., Honkanen, N., Jankala, H., Sipponen, P., and Harkonen, M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res., 57: 1276-1280, 1997.
7. Zimmermann, K. C., Sarbia, M., Weber, A. A., Borchard, F., Gabbert, H. E., and Schror, K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res., 59: 198-204, 1999.
8. Hida, T., Yatabe, Y., Achiwa, H., Muramatsu, H., Kozaki, K., Nakamura, S., Ogawa, M., Mitsudomi, T., Sugiura, T., and Takahashi, T. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res., 58: 3761-3764, 1998.
9. Δ716 knockout mice by inhibition of prostaglandin endoperoxide synthase-2 (COX-2). Cell, 87: 803-809, 1996.
10. Fujita, T., Matsui, M., Takaku, K., Uetake, H., Ichikawa, W., Taketo, M. M., and Sugihara, K. Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. Cancer Res., 58: 4823-4826, 1998.
11. Rozic, J. G., Chakraborty, C., and Lala, P. K. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis. Int. J. Cancer, 93: 497-506, 2001.
12. Kozaki, K., Koshikawa, K., Tatematsu, Y., Miyaishi, O., Saito, H., Hida, T., Osada, H., and Takahashi, T. Multi-faceted analyses of a highly metastatic human lung cancer cell line NCl-H460-LNM35 suggest mimicry of inflammatory cells in metastasis. Oncogene, 20: 4228-4234, 2001.
13. Sun, Y., Tang, X. M., Half, E., Kuo, M. T., and Sinicrope, F. A. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Cancer Res., 62: 6323-6328, 2002.
14. Lin, M. T., Lee, R. C., Yang, P. C., Ho, F. M., and Kuo, M. L. Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway. J. Biol. Chem., 276: 48997-49002, 2001.
15. Ma, L., Del Soldato, P., and Wallace, J. L. Divergent effects of new cyclooxygenase inhibitors on gastric ulcer healing: shifting the angiogenic balance. Proc. Natl. Acad. Sci. USA, 99: 13243-13247, 2002.
16. 2 production by non-small cell lung cancer cells regulates MMP-2 and CD44 in COX-2-dependent invasion. J. Biol. Chem., 277: 50828-50833, 2002.
17. 2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat. Med., 8: 289-293, 2002.
18. Stacker, S. A., Caesar, C., Baldwin, M. E., Thornton, G. E., Williams, R. A., Prevo, R., Jackson, D. G., Nishikawa, S., Kubo, H., and Achen, M. G. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med., 7: 186-191, 2001.
19. Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K., and Detmar, M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med., 7: 192-198, 2001.
20. Witmer, A. N., van Blijswijk, B. C., Dai, J., Hofman, P., Partanen, T. A., Vrensen, G. F., and Schlingemann, R. O. VEGFR-3 in adult angiogenesis. J. Pathol., 195: 490-497, 2001.
21. Banerji, S., Ni, J., Wang, S-X., Clasper, S., Su, J., Tammi, R., Jones, M., and Jackson, D. G. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol., 144: 789-801, 1999.
22. Wigle, J. T., and Oliver, G. Prox1 function is required for the development of the murine lymphatic system. Cell., 98: 769-778, 1999.
23. Rodriguez-Niedenführ, M., Papoutsi, M., Christ, B., Nicolaides, K. H., von Kaisenberg, C. S., Tomarev, S. I., and Wilting, J. Prox1 is a marker of ectodermal placodes, endodermal compartments, lymphatic endothelium and lymphangioblasts. Anat. Embryol., 204: 399-406, 2001.
24. Weninger, W., Partanen, T. A., Breiteneder-Geleff, S., Mayer, C., Kowalski, H., Mildner, M., Pammer, J., Sturzl, M., Kerjaschki, D., Alitalo, K., and Tschachler, E. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab. Investig., 79: 243-251, 1999.
25. Ebata, N., Nodasaka, Y., Sawa, Y., Yamaoka, Y., Makino, S., Totsuka, Y., and Yoshida, S. Desmoplakin as a specific marker of lymphatic vessels. Microvasc. Res., 61: 40-48, 2001.
26. Partanen, T. A., Arola, J., Saaristo, A., Jussila, L., Ora, A., Miettinen, M., Stacker, S. A., Achen, M. G., and Alitalo, K. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3 in fenestrated blood vessels in human tissues. FASEB J., 14: 2087-2096, 2000.
27. Makinen, T., Veikkola, T., Mustjoki, S., Karpanen, T., Catimel, B., Nice, E. C., Wise, L., Mercer, A., Kowalski, H., Kerjaschki, D., Stacker, S. A., Achen, M. G., and Alitalo, K. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J., 20: 4762-4773, 2001.
28. Karpanen, T., and Alitalo, K. Lymphatic vessels as targets of tumor therapy? J. Exp. Med., 194: F37-F42, 2001.
29. Stacker, S. A., Baldwin, M. E., and Achen, M. G. The role of tumor lymphangiogenesis in metastatic spread. FASEB J., 16: 922-934, 2002.
30. Chu, Y. W., Yang, P. C., Yang, S. C., Shyu, Y. C., Hendrix, M. J., Wu, R., and Wu, C. W. Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am. J. Respir. Cell Mol. Biol., 17: 353-360, 1997.
31. Papoutsi, M., Siemeister, G., Weindel, K., Tomarev, S. I., Kurz, H., Schachtele, C., Martiny-Baron, G., Christ, B., Marme, D., and Wilting, J. Active interaction of human A375 melanoma cells with the lymphatics in vivo. Histochem. Cell Biol., 114: 373-385, 2000.
32. Tsai, P. W., Shiah, S. G., Lin, M. T., Wu, C. W., and Kuo, M. L. Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-β1: a critical role of p38/NF-κB signaling pathway. J. Biol. Chem., 278: 5750-5759, 2003.
33. Shih, J. Y., Yang, S. C., Hong, T. M., Yuan, A., Chen, J. J., Yu, C. J., Chang, Y. L., Lee, Y. C., Peck, K., Wu, C. W., and Yang, P. C. Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells. J. Natl. Cancer Inst. (Bethesda), 93: 1392-1400, 2001.
34. Hong, T. M., Yang, P. C., Peck, K., Chen, J. J., Yang, S. C., Chen, Y. C., and Wu, C. W. Profiling the downstream genes of tumor suppressor PTEN in lung cancer cells by complementary DNA microarray. Am. J. Respir. Cell Mol. Biol., 23: 355-363, 2000.
35. Chen, J. J., Peck, K., Hong, T. M., Yang, S. C., Sher, Y. P., Shih, J. Y., Wu, R., Cheng, J. L., Roffler, S. R., Wu, C. W., and Yang, P. C. Global analysis of gene expression in invasion by a lung cancer model. Cancer Res. 61: 5223-5230, 2001.
36. Tamayo, P., Slonim, D., Mesirov, J., Zhu, Q., Kitareewan, S., Dmitrovsky, E., Lander, E. S., and Golub, T. R. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc. Natl. Acad. Sci. USA 96: 2907-2912, 1999.
37. 2, and FP receptor subtypes in human sclera. Investig. Ophthalmol. Vis. Sci., 42: 3182-3186, 2001.
38. Schoppmann, S. F., Birner, P., Stockl, J., Kalt, R., Ullrich, R., Caucig, C., Kriehuber, E., Nagy, K., Alitalo, K., and Kerjaschki, D. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am. J. Pathol., 161: 947-956, 2002.
39. The World Health Organization histological typing of lung tumors, Ed. 2. Am. J. Clin. Pathol., 77: 123-136, 1982.
40. Narumiya, S., Sugimoto, Y., and Ushikubi, F. Prostanoid receptors: structures, properties, and functions. Physiol. Rev., 79: 1193-1226, 1999.
41. Yang, W., Klos, K., Yang, Y., Smith, T. L., Shi, D., and Yu, D. ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma. Cancer (Phila.), 94: 2855-2861, 2002.
42. Brinson, A. E., Harding, T., Diliberto, P. A., He, Y., Li, X., Hunter, D., Herman, B., Earp, H. S., and Graves, L. M. Regulation of a calcium-dependent tyrosine kinase in vascular smooth muscle cells by angiotensin II and platelet-derived growth factor. Dependence on calcium and the actin cytoskeleton. J. Biol. Chem., 273: 1711-1718, 1998.
43. Daub, H., Weiss, F. U., Wallasch, C., and Ullrich, A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature (Lond.), 379: 557-560, 1996.
44. Saito, Y., and Berk, B. C. Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors. J. Mol. Cell. Cardiol., 33: 3-7, 2001.
45. Dikic, I., Tokiwa, G., Lev, S., Courtneidge, S. A., and Schlessinger, J. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature (Lond.), 383: 547-550, 1996.
46. Daub, H., Wallasch, C., Lankenau, A., Herrlich, A., and Ullrich, A. Signal characteristics of G protein-transactivated EGF receptor. EMBO J., 16: 7032-7044, 1997.
47. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., and DuBois, R. N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93: 705-716, 1998.
48. Jones, M. K., Wang, H., Peskar, B. M., Levin, E., Itani, R. M., Sarfeh, I. J., and Tarnawski, A. S. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat. Med., 5: 1418-1423, 1999.
49. Δ716 mouse intestinal polyps. Cancer Res., 62: 506-511, 2002.
50. Min/+ mice. Cancer Res., 62: 403-408, 2002.
51. Howe, L. R., Subbaramaiah, K., Patel, J., Masferrer, J. L., Deora, A., Hudis, C., Thaler, H. T., Muller, W. J., Du, B., Brown, A. M., and Dannenberg, A. J. Celecoxib, a selective cyclooxygenase-2 inhibitor, protects against human epidermal growth factor receptor-2 (HER-2)/neu-induced breast cancer. Cancer Res., 62: 5405-5407, 2002.
52. Subbaramaiah, K., Norton, L., Gerald, W., and Dannenberg, A. J. Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3. J. Biol. Chem., 277: 18649-18657, 2002.
53. Mottet, D., Michel, G., Renard, P., Ninane, N., Raes, M., and Michiels, C. Role of ERK and calcium in the hypoxia-induced activation of HIF-1. J. Cell. Physiol., 194: 30-44, 2003.
54. Luttrell, L. M., Daaka, Y., Della-Rocca, G. J., and Lefkowitz, R. J. G protein-coupled receptors mediate two functionally distinct pathways of tyrosine phosphorylation in rat 1a fibroblasts. Shc phosphorylation and receptor endocytosis correlate with activation of Erk kinases. J. Biol. Chem., 272: 31648-31656, 1997.
55. Zhao, W., Cavallaro, S., Gusev, P., and Alkon, D. L. Nonreceptor tyrosine protein kinase pp60c-src in spatial learning: synapse-specific changes in its gene expression, tyrosine phosphorylation, and protein-protein interactions. Proc. Natl. Acad. Sci. USA, 97: 8098-8103, 2000.
56. Tang, Y., Zhang, D., Fallavollita, L., and Brodt, P. Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor. Cancer Res., 63: 1166-1171, 2003.
57. Liu, F., Verin, A. D., Wang, P., Day, R., Wersto, R. P., Chrest, F. J., English, D. K., and Garcia, J. G. Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis. Involvement of G(iα2)-linked Rho kinase activity. Am. J. Respir. Cell Mol. Biol., 24: 711-719, 2001.